Alx Oncology Holdings (ALXO) EBIT (QoQ) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Alx Oncology Holdings | 189.80 Mn | 49.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.61% |
| Dec 31, 2025 | -2.17% |
| Sep 30, 2025 | 15.45% |
| Jun 30, 2025 | 16.25% |
| Mar 31, 2025 | -3.94% |
| Dec 31, 2024 | 6.00% |
| Sep 30, 2024 | 21.57% |
| Jun 30, 2024 | -9.97% |
| Mar 31, 2024 | -142.68% |
| Dec 31, 2023 | 266.09% |
| Sep 30, 2023 | -44.86% |
| Jun 30, 2023 | -14.20% |
| Mar 31, 2023 | 0.05% |
| Dec 31, 2022 | 12.16% |
| Sep 30, 2022 | -8.56% |
| Jun 30, 2022 | -36.54% |
| Mar 31, 2022 | 13.08% |
| Dec 31, 2021 | -15.85% |
| Sep 30, 2021 | -50.78% |
| Jun 30, 2021 | -14.72% |
| Mar 31, 2021 | -187.26% |
| Dec 31, 2020 | 266.00% |
| Sep 30, 2020 | 9.07% |
| Jun 30, 2020 | -105.78% |
| Mar 31, 2020 | 32.21% |
| Dec 31, 2019 | -154.88% |
| Sep 30, 2019 | 27.57% |